Summary
Introduction

PTPIP51 was originally detected by a yeast two-hybrid system as an interacting partner of two non-transmembrane protein-tyrosine
phosphatases, PTP1B and TcPTP [1] . As reviewed by Östman and colleagues [2] PTP1B plays a dual role in the tumourigenesis of different human cancers, either inhibiting or stimulating cancerassociated signalling processes [3] .
A study performed by Stenzinger et al. [4] [5, 6] . PTPIP51-expression in these cells was influenced by retinoic acid and 1,25(OH2)D3 [7] .
Therefore, we hypothesized that PTPIP51 may play a role in differentiation and apoptosis of cells. Independent observations by Lv and colleagues [8] as well as Roger and coworkers [9] seem to corroborate preliminary results obtained from the studies mentioned above. Due to the specific expression pattern of PTPIP51 in mammalian epidermis and stimulated by the study of Lv and colleagues [8] who demonstrated the expression of PTPIP51 mRNA in several kinds of human cancers, investigation of the PTPIP51-expression profile in non-melanoma skin cancer (keratinocyte carcinoma, KC) is of great interest. This is further underscored
by the fact that they are the most common tumours in humans with a worldwide increasing incidence [10] . Hence, KCs, [11, 12] .
namely, basal cell carcinomas (BCCs) as well as squamous cell carcinomas (SCCs) and their precancerous lesions were investigated for their PTPIP51 expression-pattern by immunohistochemistry and on a transcriptional level by RT-PCR. Keratoacanthoma (KA), an abortive malignancy that rarely progresses into an invasive squamous cell carcinoma, was also investigated for PTPIP51-expression
To obtain further information about the function of PTPIP51, co-immunostaining with a ␤-catenin-detecting antibody was performed. ␤-catenin serves as a gene-transcription factor and controls proliferation, differentiation, as well as cell-cell interaction [13, 14] . Hence, it is believed to play a central role in the development of SCCs. Moreover, the cadherin-catenin complex at epithelial adherens junctions is reported to be dephosphorylated by PTP1B [15, 16] 
Material and methods
Tissue and section preparations
The study was performed with 22 Broders [17] since this system has some shortcomings concerning the clinical application of histologic results [18] . However, the tumour thickness, a valuable predictor of the metastatic risk, was assessed [19] . 
H&E counterstaining
After obtaining photographs from immunostained samples, the coverslip of each slide was removed and the sections were subsequently stained with haematoxylin and eosin. Light microscopy was used to take H&E stained pictures of the corresponding immunohistochemical section. 
PTPIP51 antibody production
First strand synthesis
First-strand synthesis was performed using omniscript (cryomaterial) and sensiscript (paraffin material), according to the manufacturers protocol (Qiagen, Hilden, Germany).
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RT-PCR was performed on an iCycler using SYBR Green Supermix (BioRad, Munich, Germany) to visualize the respective amplicons [21] 
Results
This study demonstrates the expression of PTPIP51 mRNA and protein in the two major types of keratinocyte carcinomas (BCC and SCC), as well as in KAs and BD.
Immunohistochemical staining of PTPIP51 was assessed with respect to both, the intracellular localization (membranous, cytoplasmic and nuclear) and the staining intensity in tumour tissue and the surrounding stromal microenvironment of each entity. Figure 1 summarizes the obtained results. Fig. 2A  and B) . ␤-actin amplification served as an internal positive control [23, 24] . Fig. 3B and C) . This finding was often found to be associated with immune cell infiltrates, comprising granulocytes and lymphocytes (Fig. 4) .
RT-PCR analysis revealed the presence of PTPIP51 mRNA in all investigated tissue samples including healthy epidermis (
Immunohistochemical detection of PTPIP51 in BCCs
In some cases, however, the membranous distribution of PTPIP51 was located at the basolateral part of keratinocytes adjacent to the stromal tissue ( Fig. 3A and B) .
Immunohistochemical detection of PTPIP51 in SCCs
In contrast to BCCs, immunostaining of SCCs revealed a punctiform, mainly membranous localization of PTPIP51, thereby creating a meshwork-like appearance of adjacent keratinocytes (Fig.  5A-F) . Other SCC samples, however, showed a focal faint cytoplasmic or somewhat stronger nuclear reaction (Fig. 5B) . It was noticed that the intensity of the membranous staining of PTPIP51 was attenuated in keratinocytes adjacent to the surrounding stroma and in those encompassing intraepidermal and extraepidermal keratinization (Fig. 5B) Investigation of PTPIP51-expression in BD and keratoacanthoma resembled these results.
Surrounding stromal microenvironment of BCCs and SCCs
Healthy dermis hosts cells and structures, such as fibrocytes, glands as well as capillaries, microvessels and vessels, which are frequently but not always positive for PTPIP51 [4] . However, investigation of the stromal tumour microenviroment revealed a striking difference. There was a sheer abundance of PTPIP51-positive immune cells and endothelial cells expressing PTPIP51.
These cells differed also in their staining intensity compared to normal tissue.
A particularly strong reaction with the PTPIP51 antibody was observed in cells of the immune system infiltrating the peritumoural tissue (Fig. 6) . The same staining intensity was also noticed for immune cells infiltrating the tumour tissue itself (Fig. 4) .
Immune cells of both, the myeloid and lymphoid lineages expressed PTPIP51. Figure 6 (A and B) shows PTPIP51-positive granulocytes infiltrating the stroma of a BCC. Lymphocytes migrating through the peritumoural stroma were also positive to the PTPIP51 antibody in both stroma of BCCs and stroma of SCCs (Fig. 6C-F) .
Endothelial cells lining venous and arterial microvessels and capillaries, being located nearby tumour nests, were also PTPIP51-positive (Fig. 7) . Lumina packed with granulocytes and lymphocytes that showed a strong PTPIP51 labelling were detected quite frequently (Fig. 8) Figure 8C -F.
By comparing BCC and SCC stroma, we did not find a difference concerning the staining pattern or intensity of PTPIP51-positive immune cells and endothelial cells of microvessels and capillaries.
Doublestaining experiments of PTPIP51 (i) Ki67 and PTPIP51 MIB-1/Ki67 staining of BCC and SCC revealed that PTPIP51-positive malignant keratinocytes were not proliferating (data not shown). The same observation held true for PTPIP51 expressing immune cells infiltrating the stroma. (ii) TUNEL-assay and PTPIP51
Co-immunostaining experiments of BCCs and SCCs with the PTPIP51 antibody and in situ TUNEL-labelling demonstrated only some PTPIP51-positive malignant cells executing apoptotic cell death. This finding is exemplified by Figure 9. (iii) PTP1B and PTPIP51 An immunodetectable amount of the other PTPIP51-interacting partner, that is TCPTP was neither noticed for SCCs nor for BCCs. (iv) ␤-catenin and PTPIP51
Co-immunostaining of ␤-catenin and PTPIP51 in SCC showed a partial co-localization, which was mainly restricted to the membrane of malignant keratinocytes (Fig. 12A-C) . In a few cells, a colocalization could also be detected in the nucleus or cytoplasm. These findings are in accordance with double-staining experiments performed with HaCaT cells (Fig. 12D-F [25, 26] . [27] as well as Brasanac and coworkers [28] .
Fig. 4 H+E staining and PTPIP51-immunostaining of inflammatory cells infiltrating a BCC (A) H+E staining. Note the eosinophils migrating through the malignant tissue (B) PTPIP51-immunostaining of the same section showing a membranous and attenuated cytoplasmic localization of PTPIP51 in eosinophils and adjacent tumour cells. Bar: 50µm
Fig. 5 H+E staining and PTPIP51-immunostaining of a SCC (A) H+E staining of epidermis next to SCC tissue with a horn pearl beneath. (B) PTPIP51-immunostaining of the same section displays a strong membranous and faint nuclear staining of keratinocytes. Cells lining the horn pearl presented a more intense signal. (C) Membranous PTPIP51-immunostaining of a SCC (D) High-power view of the same section. PTPIP51 staining reveals a punctiform localization-pattern. (E) Membranous PTPIP51-immunostaining of a SCC. Some keratinocytes show an attenuated staining and some even lack PTPIP51 (F) Magnification of the same section. Bar: A, B: 50 µm, C-F: 20µm.
Fig. 6 H+E staining and PTPIP51-immunostaining of peritumoural tissue of SCC (E, F) and BCC (A, B, C, D) (A) H+E staining of two microvessels embedded in surrounding stroma of BCC. The latter is infiltrated by lymphocytes and cells (numbered and marked by circlets) and (B) Some immune cells (1-4: neutrophils and eosinophils, 5-7: lymphocytes) and the endothelial cells express PTPIP51. (C) Overview. H+E staining of BCC stroma infiltrated by lymphocytes and some granulocytes (D) PTPIP51 is expressed in some of these immune cells. (E) H+E staining of an inflammatory infiltrate mainly comprising granulocytes and lymphocytes located in the stroma of a SCC. (F) PTPIP51 is expressed in many but not all of these immune cells. Bar: A-D: 20 µm, E and F: 50µm
Discussion
Malignant tissue
A similar staining pattern for PTPIP51 and ␤-catenin could also be observed in HaCaT cells resembling precancerous lesions of SCC by its genetic mutations. [5, 6]
A cytoplasmic pool of ␤-catenin serves as a nuclear gene-transcription factor that is integrated in the Wnt-pathway, thereby controlling proliferation and differentiation, as well as development of normal tissue. Alterations of this pathway play a role in carcinogenesis and non-melanoma skin cancer in particular [13, 14, 29] . Additionally, many BCCs have somatic mutations in the PTCH1 gene ultimately leading to a disturbed hedgehog-signalling pathway. It is speculated that these alterations may lead to increased Wnt-expression [30, 31] . A stable pool of ␤-catenin, however, is bound to the adherens junctions of epithelial cells, bridging the cadherin cell-cell adhesion molecules with the actin containing cytoskeleton. Dephosphorylation of tyrosine residues on ␤-catenin by an interacting partner of PTPIP51, PTP1B maintains cadherin-actin cytoskeletal linkage [15, 16] . Bearing in mind the partial co-expression and co-localization of ␤-catenin and PTPIP51 in SCCs, one can speculate that PTPIP51 plays a role in this bridging process.
v-Src-kinase is known to phosphorylate ␤-catenin in vitro, causing destabilization of this anchorage system [32, 33] . V-Src belongs to a Src-kinase superfamily, which is well known to play a major role in the regulation of cell growth, differentiation, survival, cell shape, migration and as a protooncogene in cancer development [34, 35] immunohistochemical results presented in this study, however, revealed only a few PTPIP51-positive cells to execute apoptosis as identified by TUNEL-labelling. These findings may be explained by putative isoforms or splicing variants expressed in different tissues that lack this N-terminal sequence, which is mandatory for the execution of apoptosis [4, 8] . This hypothesis is supported by the fact that PTPIP51 was not found to be exclusively restricted to mitochondria but was present at the cellular membrane and to a lower extent in the cytosol of malignant keratinocytes [7, 8, 36] . The intracellular localization may also be explained by an in vivo interaction with PTP1B or Src-kinases.
The stem cell compartment of healthy epidermis and seminiferous epithelium harboring proliferative cell units lack PTPIP51 protein [4] . Ki [37, 38] . Hence, interactions between the tumour and the surrounding stroma play an important role in epithelial tumourigenesis [39] and can largely determine the phenotype of the tumour [40, 41] .
Peritumoural stroma
PTPIP51 was also found to be expressed in cells comprising the peritumoural stroma. This microenvironment serving as a soil for the malignant seeds provides a connective-tissue framework and includes immune and inflammatory cells, as well as fat cells and blood vessels
Angiogenesis
Tumour angiogenesis is a crucial process in tumourigenesis not only promoting tumour growth but also the progression from premalignant to malignant and invasive cancers [34, 42] . VEGF produced by malignant cells stimulates endothelial cell proliferation and angiogenesis. Malignant tissue may also induce the production of VEGF in their surrounding stroma [43] . Inhibition of VEGF activity resulted in reduced tumour angiogenesis and tumour growth. VEGF-receptor 2 blockade, in particular, induced a shift from a highly malignant to a pre-malignant, non-invasive cancer [44] .
Interestingly, observations made by Tinsley and colleagues and other research groups suggest that activated neutrophils induce
Src kinase-mediated tyrosine phosphorylation of endothelial ␤-catenin, thus leading to gap-formation and hyperpermeability of adjacent endothelial cells [45, 46] . Since endothelial cells of peritumoural capillaries and microvessels as well as a subset of neutrophils located therein were found to be positive for PTPIP51, the protein may play a role in the aforementioned processes.
Immune system
Immune cells in general play a complex and sometimes antagonistic role by promoting carcinogenesis on the one hand and keeping malignant tissue under immune surveillance on the other hand.
However, deletion of B-and T cells comprising the adaptive immune system results in attenuated pre-malignant progression and reduced skin carcinoma incidence, which is most likely caused by a halted chronic inflammation [47] . Innate immune cells promote angiogenesis and thus tumourigenesis of skin cancer by matrix metalloproteinase production. Furthermore, mast cells of the innate immune system seem to be crucial for keratinocytes to achieve hyperproliferative growth characteristics during neoplastic development [48, 49, 50] 
. PTPIP51-positive innate and adaptive immune cells invading malignant tissue, that is macrophages, eosinophils, neutrophils and lymphocytes
Fig. 12 Co-immunostaining of PTPIP51 and ß-catenin in a human SCC (A-C) and HaCaT cells (D-F) (A) PTPIP51, (B) ␤-catenin-immunostaining of the same section, (C) Overlay. Co-localization is indicated by yellow colour. (D) PTPIP51. Note the predominant membranous localization. (E)
␤
